Where does ChemoMouthPiece, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ChemoMouthPiece, LLC ranks #31,185 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ChemoMouthPiece, LLC hold?

ChemoMouthPiece, LLC holds 8 US utility patents granted between 2020 and 2024, spanning 4 technology areas.

What is ChemoMouthPiece, LLC's Innovation Score?

ChemoMouthPiece, LLC has an Innovation Score of 43.8 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ChemoMouthPiece, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for ChemoMouthPiece, LLC.

What does claim depth mean for ChemoMouthPiece, LLC's patents?

ChemoMouthPiece, LLC's patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ChemoMouthPiece, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ChemoMouthPiece, LLC

Q: What technology areas does ChemoMouthPiece, LLC focus on?

ChemoMouthPiece, LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 4 patents, ranking #1,398 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Chemomouthpiece ranks #31,185 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.

#31,185
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.8/100): 15.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R31185 · US Corporation #31,185 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 8 grants
MID-PACK #31,185/49,997
PHOTO-FINISH Charm Industrial
CPC-NARROW A61F · 4 areas
INNOV-PAR 43.8/100
CLAIMS-RICH 15.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Charm Industrial, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Chemomouthpiece’s 43.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (17%) Velocity 20.0 pts (46%) Breadth 7.1 pts (16%) Claim depth 9.2 pts (21%)

Qualcomm Incorporated · highest

85
ChemoMouthPiece · this assignee

44
3D Lighting… · lowest

7

What this shows Chemomouthpiece's Innovation Score is 43.8/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Chemomouthpiece?

Each dot is one of Chemomouthpiece’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Chemomouthpiece’s own 15.3 claims/patent is ABOVE the 10.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Chemomouthpiece vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Chemomouthpiece's grants concentrate

ChemoMouthPiece, LLC is a focused PatentsView assignee: 4 CPC subclasses with 50% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2020. By volume, Chemomouthpiece sits between Charm Industrial, Inc. and China Academy of Art.

Chemomouthpiece's three-year grant acceleration

ChemoMouthPiece, LLC shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Charm Industrial

8
Cheers Health

8
Chemgenes

8
Chemeon Surface T…

8
Chen Tian

8
Chicago Bridge &…

8
Chicago Stock Exc…

8
China Academy of…

8
Chemomouthpiece ◀

8

What this shows ChemoMouthPiece holds 8 patents at rank #31,276, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ChemoMouthPiece

By rank, the assignees closest to #31,276 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in ChemoMouthPiece's primary technology class.

Chemomouthpiece's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

ChemoMouthPiece, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	12.5%
2021	1	12.5%
2022	4	50.0%
2023	1	12.5%
2024	1	12.5%

Which technologies does ChemoMouthPiece, LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ChemoMouthPiece, LLC's patent record in context - here's where to go next.

ChemoMouthPiece, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 50% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #31,185 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ChemoMouthPiece, LLC against Charm Industrial, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.